IP-Backed Lending as Bridge Capital

Why most founders get this wrong

The most common error is treating IP-backed lending as universally available — and being surprised when the lender declines. The underwriting is selective. Lenders look for three things: an intangible-asset base that has been independently quantified, a revenue base that demonstrates the assets are commercially productive, and a covenant package the borrower can comfortably honour through the facility term.

The second common error is treating it as a substitute for equity rather than a complement to it. IP-backed lending fills the bridge between two priced rounds; it does not replace the equity needed to fund the next product cycle, the next market expansion, or the next growth phase. Founders who treat the facility as multi-purpose growth capital often breach covenants in the second year.

The third error is starting the conversation with the bank too late. Lender diligence on intangible assets typically takes 8-14 weeks — longer than equity bridges, comparable to early-stage venture-debt processes. A founder who needs the capital in 6 weeks is not a candidate for IP-backed lending; the timeline does not work.

Note: Jurisdiction matters. The UK IP-backed lending market is the most developed of any common-law jurisdiction, supported by NatWest and HSBC programmes and specialist providers. The US equivalent (Comerica, SVB-successor lenders) operates with different collateral mechanics. Canada, Australia and Ireland have nascent markets but materially fewer programmes. Cross-border facilities are uncommon — pick a lender in the borrower's home jurisdiction.

What lenders actually underwrite

Asset register quality. The lender wants to see a structured intangible-asset register that maps the company's IP, software, customer relationships, brand and other intangibles to documented value-driving evidence. The Opagio 12 framework provides this structure; lenders increasingly accept the Opagio Value Drivers Register as the underlying evidence.

Revenue stability. The covenant package will require minimum recurring-revenue thresholds and minimum cash-balance thresholds. The lender wants to see that the intangible assets are commercially productive — not just registered. A patent without a product is harder to lend against than a patent embedded in revenue.

Defensibility of the IP itself. Granted patents (not pending), registered trademarks, copyrighted software with clean chain-of-title, and well-documented trade secrets all underwrite cleanly. Pending applications, contested IP, and undocumented assets do not.

How the structure typically looks

UK IP-backed facilities most commonly take the form of a senior secured term loan, with the lender taking a fixed and floating charge over the company's assets including the registered IP. The interest profile is usually 8-12% per annum, paid quarterly, with an interest-only period of 6-12 months followed by amortisation over the remainder of the term. An arrangement fee of 1-3% of the facility amount is typical, paid at drawdown, and a non-utilisation fee on undrawn portions usually applies.

Covenants are the variable that most often produces post-close friction. Standard covenants include a minimum monthly recurring revenue threshold, a minimum cash-balance covenant, a maximum net-debt-to-revenue ratio, and reporting covenants that require monthly management accounts within 21 days of period-end. Specialist lenders sometimes layer on intangible-asset-specific covenants — for example, a covenant that the borrower will not licence, encumber, or transfer the secured IP without lender consent. The covenant package is the negotiating terrain that determines whether the facility is workable through the bridge period.

Comparing IP-backed lending to venture debt

Venture debt and IP-backed lending overlap in the bridge use-case but differ structurally. Venture debt is typically priced higher (10-13% versus 8-12%), comes with warrant coverage of 5-25% of principal (which has equity-like dilution effects), and is usually unsecured or secured by general blanket liens rather than specific IP charges. IP-backed lending typically has no warrant coverage and is secured against specific intangible assets; the lender is taking IP risk rather than pure credit risk and the structure reflects that.

For an IP-rich SaaS or deeptech company, IP-backed lending often produces a lower all-in cost than venture debt — the absence of warrants alone can be worth 3-7 percentage points of effective annual cost. For a less IP-rich business, venture debt may be the only available non-equity option. The diagnostic is whether the intangible-asset register is rich enough to underwrite the facility size required.

How to apply it to your round

The asset register is the precondition. Without a structured intangible-asset register, the lender either declines or takes 12+ weeks to assemble what the founder should already have. With the register in place, the diligence narrows to verifying the underlying evidence — the typical timeline compresses to 6-8 weeks and the rate sometimes improves with the structured documentation.

Before the first lender call. Run the Round Readiness Diagnostic. Populate the Value Drivers Register. Quantify each driver with the underlying evidence. Document IP grants, registrations, contracts, and revenue attribution. The pack should be lender-ready before the first conversation.

During the diligence. Expect the lender to verify the asset register independently — typically through a third-party intangible-asset valuation specialist. The Opagio register accelerates this stage because it produces a structured artefact that the valuation specialist can verify rather than reconstruct.

Post-close. The covenant reporting package becomes a monthly discipline. Build the reporting cadence into the finance function from the day the facility funds; a lender that sees a clean reporting package in month one is a different lender from one that sees the first report after a covenant near-breach in month nine.